1. Home
  2. STDN vs BCRX Comparison

STDN vs BCRX Comparison

Compare STDN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Nuclear Inc. Class A Common Stock

STDN

Standard Nuclear Inc. Class A Common Stock

N/A

Current Price

$13.08

Market Cap

1.9B

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.78

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STDN
BCRX
Founded
N/A
1986
Country
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
STDN
BCRX
Price
$13.08
$8.78
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$20.82
AVG Volume (30 Days)
823.4K
3.7M
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$6.00
52 Week High
$17.34
$11.22

Technical Indicators

Market Signals
Indicator
STDN
BCRX
Relative Strength Index (RSI) 51.34 46.31
Support Level $11.58 $8.79
Resistance Level $13.80 $9.31
Average True Range (ATR) 1.07 0.32
MACD -0.19 -0.02
Stochastic Oscillator 28.48 40.04

Price Performance

Historical Comparison
STDN
BCRX

About STDN Standard Nuclear Inc. Class A Common Stock

Standard Nuclear Inc is an independent advanced nuclear fuel company. The company designs, engineers, and manufactures advanced nuclear fuels, with a primary focus on TRISO fuel for advanced reactors. Its operations include industrial-scale TRISO fuel manufacturing and the development of fuel for advanced reactors that utilize TRISO fuel. The company operates in a single operating and reportable segment, as it is engaged in a single business activity of TRISO production. It derives revenue from fuel development and services agreements. Geographically, the maximum revenue is generated from the United States.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: